Laser treatment for diabetic eye disease and its effect on cornea cells
Part of Eyes & vision clinical trials.
This study looks at how a common laser treatment for diabetic eye disease (panretinal photocoagulation) affects the cells on the inside of the cornea. It may help doctors understand if this treatment is safe for the cornea.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been newly diagnosed with proliferative diabetic retinopathy (advanced diabetic eye disease).
- You need panretinal photocoagulation (a laser treatment for the back of the eye).
- You do not have a history of any corneal disease (problems with the clear front part of your eye).
- You have not had any eye surgery before.
- You do not have glaucoma (high eye pressure) or active inflammation inside your eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a different pattern of laser treatment for people with diabetic eye disease (proliferative diabetic retinopathy) that has started growing abnormal blood vessels. The goal is to see if this pattern works well or better than the standard approach.
This study compares having laser treatment for diabetic eye disease in one session versus spreading it over multiple sessions. The goal is to find out if one approach is better for your eyes and easier for you.
This trial tests if a targeted laser treatment guided by a special eye scan can slow the progression of blocked blood vessels in the retina for people with diabetes-related eye disease. It may help preserve vision by treating damaged areas before they worsen.
This study looks at how people with severe nonproliferative diabetic retinopathy do after they have vitrectomy (a type of eye surgery). The goal is to better predict prognosis and possibly improve care planning after surgery.
This trial compares two treatments for early diabetic retinopathy—a condition where high blood sugar damages blood vessels in the eye. Researchers want to see if removing fluid from inside the eye (vitrectomy) works better than laser treatment to prevent vision loss.
This trial studies cells from eyes affected by severe diabetic retinopathy (PDR). It aims to better understand the disease by analyzing tissue from patients who are already having eye surgery.
Hear when a new Panretinal Photocoagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.